Background-Inducible nitric oxide synthase (iNOS) is expressed by leukocytes and smooth muscle cells in atherosclerotic lesions. To test whether NO produced by iNOS deficiency affects atherosclerosis, we studied apoE/iNOS-double knockout (dKO) and apoE-knockout (KO) control animals fed a "Western-type" diet. Methods and Results-After 16 weeks of Western-type diet, the aortic lesion area in apoE/iNOS-dKO males and females was significantly reduced, by 22% and 21%, respectively, compared with apoE-KO males and females. This effect was more pronounced after 24 weeks of Western-type diet, after which lesion formation in male and female dKO mice was reduced by 38% and 40%, respectively. Plasma levels of lipoperoxides in apoE/iNOS-dKO mice (2.0Ϯ0.23 mol/L) were significantly lower than in apoE-KO control animals (3.2Ϯ0.44 mol/L; Pϭ0.02). To test whether substrate deficiency plays a role in the proatherogenic actions of iNOS, we administered L-arginine to apoE-KO animals for 16 and 24 weeks. L-Arginine treatment did not affect lesion formation in apoE-KO animals fed a Western-type diet.
is constitutively expressed by the endothelium, the neuronal and inducible NOSs (nNOS [NOS1] and iNOS [NOS2]) are usually not detectable in undiseased vascular tissue. In human atherosclerotic lesions, however, all 3 isoforms are present. 1 iNOS expression has been localized to vascular smooth muscle cells and mononuclear leukocytes in early and advanced atherosclerotic lesions. 2 NOSs use L-arginine as substrate, converting a terminal guanidino nitrogen to NO. The activities of eNOS and nNOS, the constitutive isoforms, are regulated by intracellular Ca 2ϩ concentration. In contrast, iNOS expression is induced by microbial endotoxins or cytokine stimulation, and its activity does not vary with intracellular Ca 2ϩ concentration. Although strong evidence suggests that eNOS plays an important role in protection of the vessel wall from atherosclerosis, the role of iNOS in modulating the development of atherosclerosis is unclear.
iNOS may contribute to lesion formation by increasing oxidative stress in the vessel wall. 3 Reactive intermediates derived from NO accelerate LDL oxidation under acidic conditions. 4 NO can react with superoxide to form peroxynitrite, a strong oxidant, with resultant generation of hydroxyl radicals. 5, 6 Peroxynitrite also promotes LDL lipid oxidation in vitro 6, 7 and nitrosylates protein tyrosine residues in atherosclerotic lesions. 8 Because superoxide reacts with NO to form peroxynitrite faster than superoxide can be scavenged by superoxide dismutase, 9 the rate of superoxide formation in the vessel wall can profoundly influence the fate of NO.
To study the contribution of iNOS to lesion formation, we combined a genetic model of iNOS deficiency with a mouse model of atherosclerosis, the hyperlipidemic apolipoprotein E (apoE)-knockout (KO) mouse. ApoE-KO mice develop atherosclerotic lesions on a normal chow diet in a distribution closely resembling that in human disease. 10 Disease progression can be substantially accelerated by feeding a "Western-type" atherogenic diet. We compared lesion formation in Western-type diet-fed apoE/iNOS-double knockout (dKO) mice and apoE-KO mice. This genetic approach overcomes problems with specificity and variability of NOS inhibitors. To avoid effects due to genetic background, we used highly inbred animals, all backcrossed 10 generations to the C57BL6 strain.
We show that genetic deficiency of the inducible NOS protects from atherosclerosis in apoE/iNOS-dKO mice. Furthermore, apoE/iNOS-dKO mice had significantly lower plasma levels of lipid peroxides, suggesting that the reduction in lesion formation may be due to a decrease in lipid peroxidation.
Methods
Mice iNOS-KO and apoE-KO animals were obtained from Jackson Laboratories. 11, 12 All mice were backcrossed for 10 generations to a C57BL/6J genetic background. iNOS-KO and apoE-KO animals were crossed to generate double-heterozygous mice, which were intercrossed and the offspring genotyped for iNOS and apoE by polymerase chain reaction. ApoE-KO animals that were wild-type or knockout for iNOS were weaned at 21 days and fed a Western-type diet (42% of total calories from fat; 0.15% cholesterol; Harlan Teklad) for 16 or 24 weeks. L-Arginine was given to apoE-KO mice by supplementing the drinking water with 2.5% L-arginine, a method previously shown to reduce lesion formation in hypercholesterolemic rabbits and LDL receptor-knockout mice. 13, 14 All procedures were approved by the institutional animal use and care committee and conform with NIH guidelines.
Lesion Assessment
The aorta was dissected and analyzed as previously described. 15 Animals were euthanized with pentobarbital (80 g/kg IP), and the aorta was perfused with PBS (pH 7.4), dissected from the aortic valve to the iliac bifurcation, and fixed in 4% paraformaldehyde overnight. Adventitial tissue was removed, and the aorta was opened longitudinally and pinned onto a black wax surface with micro needles (Fine Science Tools). Serial images of the submerged vessels were captured with a video camera and a still 35-mm camera. Lipid-rich intraluminal lesions were stained with Sudan IV. 15 Image analysis was performed with Image Pro Plus (version 3.0.1; Media Cybernetics). The amount of aortic lesion formation in each animal was measured as percent lesion area per total area of the aorta.
Tissue Preparation and Histology
Animals were euthanized with pentobarbital (80 g/kg IP) and perfused with 0.9% NaCl followed by 10% phosphate-buffered formalin through a catheter placed in the left ventricle. The heart was fixed in 10% phosphate-buffered formalin for 48 hours and embedded in paraffin. Serial 5-m sections were taken from the aortic valve area. Sections were stained with hematoxylin-eosin, Masson's trichrome, Weigert's method for elastic fibers, and von Kossa stain for mineral salts.
Immunohistochemistry
Immunohistochemistry was carried out on paraffin-embedded sections with a goat anti-mouse IgG1 antibody raised against iNOS (clone 2, N52920, Transduction Laboratories). A Vectastain ABC kit with DAB as the substrate was used for visualization.
Lipids and Lipoprotein Characterization
Animals were fasted for 4 hours, and blood was drawn from the left ventricle of anesthetized animals. Plasma total cholesterol was measured with Sigma kit 352. Lipoprotein cholesterol distribution of plasma samples was evaluated after fractionation by fast protein liquid chromatography (FPLC) gel filtration. Plasma (200 L) was fractionated on a Superose 6 column with an ÄKTA-FPLC (Amersham Pharmacia Biotech) system. Cholesterol concentrations were measured with a microtiter plate assay (Sigma kit 352; Spectra MAX 250; Molecular Devices).
Plasma Lipoperoxide Measurement
Malondialdehyde-thiobarbituric acid (MDA-TBA) adduct was measured by high-performance liquid chromatography (HPLC) as described. 16 Blood was drawn from the left ventricle of animals under pentobarbital anesthesia (40 to 60 mg/kg IP) and collected in tubes containing EDTA. Plasma was separated, and fractionation of the protein-free extract was done with a C18 column (Micro Bondapak, Waters) in an ÄKTApurifier HPLC system (Amersham Pharmacia Biotech). A standard curve was constructed with tetraethoxypropane standards.
Statistical Analysis
Statistical analysis was performed with StatView 4.51 (Abacus Concepts, Inc). Two-way ANOVA was used for repeated measures, followed by Scheffé's F test. A probability value of PϽ0.05 was considered significant.
Results
Inspection of the longitudinally opened Sudan IV-stained aorta showed that apoE/iNOS-dKO and apoE-KO animals developed lesions at typical sites of predilection, namely, at branch vessels and curvature ( Figure 1 ). After 16 weeks of Western-type diet, analysis of hematoxylin and eosinstained and Masson's trichrome-stained sections through the aortic valve showed advanced lesions with fibrous cap and necrotic core in apoE/iNOS-dKO and apoE-KO control animals ( Figure 2 ). von Kossa-stained sections showed calcification of the aortic valve leaflets in apoE/ iNOS-dKO and apoE-KO animals. Sections stained with Weigert's method for elastic fibers revealed thinning of the vessel wall in apoE-KO that was not seen in apoE/iNOS-dKO animals. Atherosclerotic lesions of apoE-KO animals stained strongly for iNOS immunoreactivity, but lesions from apoE/iNOS-dKO animals did not ( Figure 2 ).
The body weight, total area of the aorta, and total cholesterol did not differ between apoE-KO mice and apoE/iNOS-dKO mice within each sex (Table) . Female mice, however, were smaller than male mice of the same genotype. The lipoprotein profile, as assessed by FPLC, also did not differ between apoE-KO mice and apoE/iNOS-dKO mice (data not shown).
After 16 weeks of Western-type diet, the aortic lesion areas in apoE/iNOS-dKO males and females were reduced by 22% and 21%, respectively (males: mean area 11.4Ϯ0.7%, nϭ9; females: mean area 14.2Ϯ0.7%, nϭ7), compared with apoE-KO males and females (mean area 14.6Ϯ0.8%, nϭ7, Pϭ0.035, and 18.0Ϯ0.6%, nϭ8, Pϭ0.005) (Figure 3 , left). After 24 weeks of Western-type diet, lesion formation in male and female dKO mice was reduced by 38% and 40%, respectively (males: mean area 19.5Ϯ1.5%, nϭ9; females: mean area 19.2Ϯ1.4%, nϭ8), compared with apoE-KO control animals (males: mean area 31.3Ϯ1.6%, nϭ11, Pϭ0.0006; females: mean area 32.1Ϯ3.3%, nϭ6, Pϭ0.0017) (Figure 3, right) .
L-Arginine-supplemented drinking water was given to male and female apoE-KO mice fed the Western-type diet. After 16 weeks of Western-type diet and L-arginine supplementation, lesion formation in male and female apoE-KO mice (males: mean area 16.2Ϯ1.1%, nϭ5, PՆ0.6; females: mean area 18.7Ϯ1.0%, nϭ5, PՆ0.9) did not differ from that in apoE-KO mice fed the Western-type diet alone (Figure 4 , left). This result did not change when we examined the 24-week time point (males: mean area 30.7Ϯ2.1%, nϭ8, PՆ0.9; females: mean area 27.7Ϯ1.0%, nϭ8, PՆ0.5) with apoE-KO animals fed the Western-type diet alone for the same amount of time (Figure 4 , right). Values are meanϮSEM; nϭnumber of mice. All animals received the Western-type diet for 16 weeks. There was no statistically significant difference between the apoE/iNOS-dKO and apoE-KO control animals for any of the parameters. 
Characteristics of ApoE-KO and apoE/iNOS-dKO Mice

Kuhlencordt et al Reduced Atherosclerosis in ApoE/iNOS-KO Mice
Plasma levels of lipoperoxides, assayed as MDA-TBA adducts by HPLC, were significantly reduced in apoE/iNOS-dKO mice (2.01Ϯ0.23 mol/L, nϭ12) compared with apoE-KO control animals (3.20Ϯ0.44 mol/L, nϭ7, Pϭ0.018) at the 4-month time point, as seen in Figure 5 . In good agreement with the basal lipoperoxide levels measured in rats (1.4 mol/L) by Wong et al, 16 the basal plasma lipoperoxide level in wild-type C57BL6 mice on a normal chow diet averaged 0.99Ϯ0.11 mol/L (nϭ8), which was significantly lower than the values measured in apoE/iNOS-dKO mice (Pϭ0.037) and apoE-KO animals (PՅ0.0001).
Discussion
The development of atherosclerosis is a dynamic process that results from excessive inflammatory and fibroproliferative responses. 17 NO may normally prevent atherosclerosis by inhibiting smooth muscle cell proliferation, inhibiting platelet aggregation and adhesion, and inhibiting leukocyte activation and adhesion. 18 -21 Although eNOS is an important regulator of normal vascular function, the inducible isoform and the neuronal isoform are usually not detectable in undiseased vessels. 1 In human atherosclerotic lesions, however, all 3 isoforms of NOS-iNOS, nNOS, and eNOS-are present. 1 In contrast to nNOS and eNOS, iNOS is fully active at basal Ca 2ϩ levels. Once activated, iNOS is capable of generating higher NO concentrations, in the micromolar range, with higher substrate demands and with less regulation than the constitutive isoforms.
The role of iNOS in vascular pathology is variable and poorly defined in atherosclerosis. Transplant atherosclerosis is exacerbated in a model of chronic cardiac rejection in iNOS-KO mice, suggesting a protective role for iNOS. 22 The same authors reported, however, that iNOS deficiency reduced inflammatory infiltrates and lowered rejection scores in a model of acute cardiac allograft rejection, suggesting a pathological role for iNOS. 23 Recently, Knowles et al 24 reported that absence of iNOS had no effect on atherosclerosis development in apoE/iNOS-dKO mice, but details were not provided. The potential effects of iNOS in atherosclerosis have clinical implications beyond a molecular mechanism of atherogenesis as well. Gene transfer of iNOS to injured vascular segments reduces neointima formation in normocholesterolemic animals, 25 providing impetus for studies involving gene transfer of iNOS in patients. Thus, a possible involvement of iNOS in the development of atherosclerotic lesions has important clinical implications.
In the present study, we show that genetic deficiency of iNOS decreases atherosclerosis in apoE/iNOS-dKO mice. Male and female apoE/iNOS-dKO animals showed significant 22% and 21% reductions in aortic lesion area after 16 weeks and 38% and 40% reductions after 24 weeks of Western-type diet, respectively. Thus, protection from lesion formation in genetic iNOS deficiency increases over time, suggesting that iNOS accelerates lesion progression from an early time point and that the amount of iNOS-mediated injury increases over time.
Reduction in lesion formation was associated with a decrease in plasma lipoperoxide concentrations. Plasma levels of MDA, a highly reactive compound generated during lipid peroxidation by phagocytic cells, were significantly higher in apoE-KO animals than in apoE/iNOS-dKO animals and normocholesterolemic C57BL6 mice. In addition, MDA levels in apoE/iNOS-dKO animals were significantly higher than in C57BL6 animals. This demonstrates that iNOS is not the sole contributor to the elevated MDA levels seen in Western-type diet-fed apoE-KO mice. The decrease in atherosclerotic lesion area and lowered plasma lipoperoxide levels are not due to secondary changes in plasma total cholesterol, lipoprotein distribution, or body weight, because none of these parameters differed between apoE-KO and apoE/iNOS-dKO animals. NO has both oxidant and antioxidant effects. NO may inhibit lipid peroxidation by scavenging lipid radicals and terminating the peroxidative chain reaction. 26 Conversely, NO reacts with superoxide to form peroxynitrite. Peroxynitrite can oxidize LDL, nitrosylate tyrosine residues within proteins, and generate hydroxyl radicals. Hydroxyl radicals, in turn, can attack unsaturated fatty acids to yield lipid hydroperoxides. 6 MDA generated during lipid oxidation can itself modify LDL so that it is recognized by the macrophage scavenger receptor, an important step in foam cell formation. 27, 28 It has been suggested that the balance between local concentrations of NO and O 2
Ϫ may determine whether peroxynitrite forms and lipid peroxidation occurs. 29 Conditions that favor peroxynitrite formation would favor lipid peroxidation, whereas excess NO without O 2
Ϫ may block lipid peroxidation by scavenging peroxyl radicals. The role of iNOS in this balance is complex, because iNOS can generate not only NO but also O 2 Ϫ , particularly under conditions of decreased L-arginine availability. 30, 31 L-Arginine supplementation reduces atherosclerosis development in hyperlipidemic rabbits and in LDL receptor-knockout mice. 13, 14 To test whether L-arginine supplementation modulates atherosclerosis in apoE-KO animals, we supplemented the drinking water of Western-type diet-fed animals with 2.5% L-arginine. After 16 and 24 weeks of L-arginine supplementation, the lesion area in apoE-KO mice did not differ from animals that were fed the Western-type diet alone. There are several potential explanations for this finding. First, in vitro studies show that O 2
Ϫ production by iNOS is inhibited only by high L-arginine concentrations. Whereas O 2
Ϫ production by nNOS is completely blocked by 100 mol/L L-arginine, iNOS-mediated O 2
Ϫ formation was essentially unaltered. Even in the presence of 1 mmol/L L-arginine, O 2
Ϫ production was only partially blocked. Physiological cytosolic L-arginine concentrations (200 to 800 mol/L) may thus not be able to block O 2 Ϫ generation from iNOS. Second, if there are additional sources of O 2
Ϫ that are independent of iNOS, reducing the contribution of iNOS to O 2 Ϫ formation may not affect the net amount of O 2 Ϫ present. In fact, by providing more NO, L-arginine supplementation may increase the amount of OONO Ϫ formed under these conditions. Third, the effects of L-arginine on atherosclerosis may depend on the relative amounts of the 3 NOS isoforms and their contribution to NO and O 2 Ϫ production in the various animal models of atherosclerosis. For example, L-arginine may result in increased eNOS production of NO, accounting for protection in some models independent of iNOS. Our results suggest that L-arginine may not be important in reducing iNOS-mediated atherogenesis in Western-type diet-fed apoE-KO animals. Additional cofactor deficiency, low local L-arginine concentration despite supplementation, or the fact that iNOS is not substrate deficient in first place cannot be excluded, however. Our results differ from those in LDL receptor-KO mice, 14 in which L-arginine supplementation reduced atherosclerosis. In addition to the above-mentioned factors, the 2 animal models differ in several important ways. Our apoE-KO mice were fed a Western-type diet containing 0.15% cholesterol, whereas the LDL receptor-KO mice were fed a high-cholesterol diet containing 1.25% cholesterol. Lesion areas are much greater in the apoE-KO model than the LDL receptor-KO model. 32 While our manuscript was in preparation, Knowles et al 24 reported that iNOS deficiency has no effect on atherosclerosis development in apoE/iNOS-dKO mice. The difference in phenotype seen in the 2 studies may be due to the mixed genetic background of the animals, their use of normal chow diet rather than our use of a Western-type diet, or our study of later time points and the different assay for atherosclerosis development used. A more recent report confirms our results that iNOS deficiency reduces atherosclerosis in apoE-KO mice. 33 Our study differs, however, because we assayed en face lesion area as opposed to aortic root lesions, we used animals that were all backcrossed to the C57BL6 strain, and we provide data about levels of plasma MDA-TBA adducts.
In summary, genetic deficiency of iNOS decreases atherosclerosis in Western-type diet-fed apoE-KO animals. The reduction in atherosclerosis in dKO animals was associated with decreased plasma levels of lipoperoxides, suggesting that reduction in iNOS-mediated oxidative stress may explain the protection from lesion formation in dKO animals. L-Arginine supplementation did not change lesion area in apoE-KO mice after 16 and 24 weeks of Western-type diet.
